INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,279,377 | -12.5% | 40,461 | +12.8% | 0.07% | -9.0% |
| Q2 2023 | $1,462,738 | +8.6% | 35,869 | -0.7% | 0.08% | -6.0% |
| Q1 2023 | $1,346,863 | +234.7% | 36,138 | +213.3% | 0.08% | +219.2% |
| Q4 2022 | $402,456 | -28.6% | 11,535 | +14.5% | 0.03% | -36.6% |
| Q3 2022 | $564,000 | +12.8% | 10,077 | +4.3% | 0.04% | +28.1% |
| Q2 2022 | $500,000 | -35.6% | 9,665 | -9.6% | 0.03% | -3.0% |
| Q1 2022 | $777,000 | -44.7% | 10,686 | -10.0% | 0.03% | -28.3% |
| Q4 2021 | $1,404,000 | -20.1% | 11,877 | -9.3% | 0.05% | -22.0% |
| Q3 2021 | $1,757,000 | +479.9% | 13,098 | +598.2% | 0.06% | +490.0% |
| Q2 2021 | $303,000 | – | 1,876 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |